Schering oncology development VP
Schering-Plough's new VP-global clinical development-oncology is former Aventis VP-Oncology Susan Arbuck. Arbuck has also held the position of VP-oncology clinical research with Bristol-Myers Squibb and headed the National Cancer Institute's developmental chemotherapy section (1"The Pink Sheet" Sept. 10, 2001, p. 32)...
You may also be interested in...
Susan Arbuck, MD, joins Bristol-Myers Squibb Sept. 4 as VP-oncology clinical research. Arbuck formerly headed the National Cancer Institute's developmental chemotherapy section
Cipla has expanded its partnership with Alvotech to cover the commercialization of five biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.
Lack of official explanation about how the exchange of critical information will progress pending the launch of the EU’s medical device database, Eudamed3, has left many confused. New guidance lights the way forward.